These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4248380)

  • 1. Effect of growth of Walker 256 carcinosarcoma of the fibrinolytic system of the rat plasma and urine.
    Mootse G; Agostino D; Cliffton EE
    Tumori; 1970; 56(2):71-81. PubMed ID: 4248380
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of proteins and fibrinolysis in patients with glomerulonephritis.
    Wardle EN; Menon IS; Rastogi SP
    Br Med J; 1970 May; 2(5704):260-3. PubMed ID: 4246192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiology of fibrinolysis.
    Astrup T; Thorsen S
    Med Clin North Am; 1972 Jan; 56(1):153-62. PubMed ID: 4257246
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effect of normal and cancerous tissues of the bladder on plasminogen activation.
    Hisazumi H
    Invest Urol; 1973 Nov; 11(3):258-62. PubMed ID: 4270696
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proactivator-activator system in human plasma fibrinolysis: studies on the synthetic fibrinolytic system composed of functionally pure fibrinogen, plasminogen and proactivator, separated from human plasma].
    Okamoto U
    Nihon Seirigaku Zasshi; 1972 Mar; 34(3):147-55. PubMed ID: 4262660
    [No Abstract]   [Full Text] [Related]  

  • 6. Trypsin inhibitor excretion due to fibrinolytic activation of cat plasma.
    Mootse G; Cliffton EE
    Proc Soc Exp Biol Med; 1968 Oct; 129(1):70-3. PubMed ID: 4234874
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinolytic activity in Behçet's disease].
    Kogure M; Motoji K
    Nippon Ganka Gakkai Zasshi; 1972 Mar; 76(3):114-21. PubMed ID: 4261805
    [No Abstract]   [Full Text] [Related]  

  • 8. Molar concentrations of fibrinolytic components, especially free fibrinolysin, in vivo.
    Nanninga LB
    Thromb Diath Haemorrh; 1975 Apr; 33(2):244-55. PubMed ID: 124474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on plasminogen activators. II. A method for the separation of purified urokinase from small samples of urine.
    Hamberg U; Savolainen ML
    Acta Chem Scand; 1966; 20(9):2551-8. PubMed ID: 5965138
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemia.
    Lassman HB; Wilkens HJ; Back N
    J Pharmacol Exp Ther; 1974 May; 189(2):317-26. PubMed ID: 4275231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravascular coagulation in solid Walker carcinosarcoma 256].
    Hilgard P; Ziegler R; Minne H; Schmitt W
    Schweiz Med Wochenschr; 1971 Apr; 101(13):478-80. PubMed ID: 5558916
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinolytic activity of proactivator and activator in human urine.
    Kamada T
    Nihon Hoigaku Zasshi; 1967 Nov; 21(6):541-51. PubMed ID: 4233846
    [No Abstract]   [Full Text] [Related]  

  • 13. [Parallels between the development of anemia and hypoglycemia in rats carrying experimental Walker carcinosarcoma 256 and Yoshida sarcoma tumors].
    de la Piedra C; Castro Mendoza HJ
    Rev Clin Esp; 1978 Dec; 151(5):355-7. PubMed ID: 741018
    [No Abstract]   [Full Text] [Related]  

  • 14. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
    COON WW
    Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemistry of fibrinolysis].
    Schwick HG
    Thromb Diath Haemorrh Suppl; 1967; 22():27-46. PubMed ID: 4231070
    [No Abstract]   [Full Text] [Related]  

  • 16. Alterations in fibrinogen, plasminogen, and inhibitors of plasmin with the growth of V2 carcinoma in rabbits.
    Mootse G; Agostino D; Cliffton EE
    J Natl Cancer Inst; 1965 Sep; 35(3):567-72. PubMed ID: 4220790
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the fibrinolytic enzyme system in obesity.
    Bennett NB; Ogston CM; McAndrew GM; Ogston D
    J Clin Pathol; 1966 May; 19(3):241-3. PubMed ID: 4223015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical pharmacology of the fibrinolysin system of the rat. 3. The mechanism of phenformin (1-(beta-phenethyl)-biguanide)-induced fibrinolytic activity.
    Lassman HB; Back N
    J Pharmacol Exp Ther; 1974 May; 189(2):333-43. PubMed ID: 4275233
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
    CLIFFTON EE; AGOSTINO D
    J Natl Cancer Inst; 1964 Nov; 33():753-63. PubMed ID: 14231149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.